CLS Holdings USA, Inc. Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' EQUITY (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights

STOCKHOLDERS' EQUITY (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights - $ / shares	12 Months Ended
	May 31, 2024	May 31, 2023	Sep. 15, 2022	May 31, 2022
Class of Warrant or Right [Line Items]
Exercise Price			$ 0.4
Number of warrants outstanding (in Shares)	20,726,901	21,181,449		1,729,924
Weighted average remaining contractual life	1 year 3 months 18 days
Weighted average exercise price of outstanding warrants	$ 0.43	$ 0.46		$ 1.98
Number of warrants exercisable (in Shares)	20,726,901
Weighted average exercise price of exercisable warrants	$ 0.43
Warrants Exercisable at $0.40 [Member]
Class of Warrant or Right [Line Items]
Exercise Price	$ 0.4
Number of warrants outstanding (in Shares)	20,232,775
Weighted average remaining contractual life	1 year 3 months 14 days
Weighted average exercise price of outstanding warrants	$ 0.4
Number of warrants exercisable (in Shares)	20,232,775
Weighted average exercise price of exercisable warrants	$ 0.4
Warrants Exercisable at $1.60 [Member]
Class of Warrant or Right [Line Items]
Exercise Price	$ 1.6
Number of warrants outstanding (in Shares)	191,094
Weighted average remaining contractual life	1 year 3 months 14 days
Weighted average exercise price of outstanding warrants	$ 1.6
Number of warrants exercisable (in Shares)	191,094
Weighted average exercise price of exercisable warrants	$ 1.6
Warrants Exercisable at $1.65 [Member]
Class of Warrant or Right [Line Items]
Exercise Price	$ 1.65
Number of warrants outstanding (in Shares)	303,032
Weighted average remaining contractual life	1 year 5 months 8 days
Weighted average exercise price of outstanding warrants	$ 1.65
Number of warrants exercisable (in Shares)	303,032
Weighted average exercise price of exercisable warrants	$ 1.65